Patient-reported outcomes in a phase II, North American study of alectinib in patients with ALK-positive, crizotinib-resistant, non-small cell lung cancer
| Title: | Patient-reported outcomes in a phase II, North American study of alectinib in patients with ALK-positive, crizotinib-resistant, non-small cell lung cancer |
|---|---|
| Authors: | Ou, Sai-Hong Ignatius, Socinski, Mark A, Gadgeel, Shirish, Gandhi, Leena, West, Howard, Chiappori, Alberto Alejandro, Cohen, Victor, Riely, Gregory J, Smoljanovic, Vlatka, Bordogna, Walter, Wright, Elaine, Debusk, Kendra, Zeaiter, Ali, Shaw, Alice T |
| Source: | In ESMO Open 2018 3(5) |
| Database: | ScienceDirect |
| ISSN: | 20597029 |
|---|---|
| DOI: | 10.1136/esmoopen-2018-000364 |
| Published in: | ESMO Open |
| Language: | English |